PEN Penumbra Inc

Price (delayed)

$263

Market cap

$10.04B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$10.21B

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses ...

Highlights
PEN's gross profit is up by 13% year-on-year and by 2.5% since the previous quarter
PEN's revenue is up by 13% year-on-year and by 2.1% since the previous quarter
The net income has plunged by 138% YoY but it has soared by 93% from the previous quarter
PEN's EPS has shrunk by 136% YoY but it has soared by 94% QoQ
Penumbra's debt has increased by 36% YoY and by 8% QoQ
Penumbra's quick ratio has decreased by 15% YoY

Key stats

What are the main financial stats of PEN
Market
Shares outstanding
38.18M
Market cap
$10.04B
Enterprise value
$10.21B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10
Price to sales (P/S)
11.75
EV/EBIT
2,622.55
EV/EBITDA
361.78
EV/Sales
12.05
Earnings
Revenue
$847.13M
EBIT
$3.89M
EBITDA
$28.21M
Free cash flow
-$74.96M
Per share
EPS
-$0.05
Free cash flow per share
-$1.98
Book value per share
$26.3
Revenue per share
$22.39
TBVPS
$29.69
Balance sheet
Total assets
$1.37B
Total liabilities
$372.03M
Debt
$235.77M
Equity
$998.86M
Working capital
$610.77M
Liquidity
Debt to equity
0.24
Current ratio
5.21
Quick ratio
2.7
Net debt/EBITDA
5.88
Margins
EBITDA margin
3.3%
Gross margin
63.2%
Net margin
-0.2%
Operating margin
0.7%
Efficiency
Return on assets
-0.2%
Return on equity
-0.2%
Return on invested capital
0.4%
Return on capital employed
0.3%
Return on sales
0.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PEN stock price

How has the Penumbra stock price performed over time
Intraday
-1.85%
1 week
6.87%
1 month
-0.64%
1 year
24.91%
YTD
18.22%
QTD
18.22%

Financial performance

How have Penumbra's revenue and profit performed over time
Revenue
$847.13M
Gross profit
$535.21M
Operating income
$6.08M
Net income
-$2M
Gross margin
63.2%
Net margin
-0.2%
Penumbra's operating income has surged by 181% YoY and by 116% QoQ
PEN's operating margin has soared by 170% YoY and by 115% from the previous quarter
The net income has plunged by 138% YoY but it has soared by 93% from the previous quarter
Penumbra's net margin has shrunk by 129% YoY but it has surged by 95% QoQ

Growth

What is Penumbra's growth rate over time

Valuation

What is Penumbra stock price valuation
P/E
N/A
P/B
10
P/S
11.75
EV/EBIT
2,622.55
EV/EBITDA
361.78
EV/Sales
12.05
PEN's EPS has shrunk by 136% YoY but it has soared by 94% QoQ
The stock's P/B is 35% above its last 4 quarters average of 7.4 but 7% below its 5-year quarterly average of 10.8
PEN's equity is up by 4.7% year-on-year and by 2.6% since the previous quarter
PEN's price to sales (P/S) is 34% higher than its last 4 quarters average of 8.8 and 4% higher than its 5-year quarterly average of 11.3
PEN's revenue is up by 13% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Penumbra business performance
PEN's ROS has soared by 150% YoY and by 110% QoQ
The company's return on invested capital has surged by 144% YoY and by 110% QoQ
The ROA has plunged by 140% YoY but it has soared by 91% from the previous quarter
The ROE has plunged by 129% YoY but it has soared by 94% from the previous quarter

Dividends

What is PEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PEN.

Financial health

How did Penumbra financials performed over time
PEN's total liabilities is up by 28% YoY and by 7% from the previous quarter
Penumbra's quick ratio has decreased by 15% YoY
Penumbra's debt is 76% lower than its equity
Penumbra's debt has increased by 36% YoY and by 8% QoQ
PEN's debt to equity is up by 33% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.